Logo image of OG

ONION GLOBAL LTD (OG) Stock Fundamental Analysis

USA - NYSE:OG - US68277G1076 - ADR

0.238 USD
-0.01 (-4.8%)
Last: 1/3/2023, 8:21:22 PM
0.1799 USD
-0.06 (-24.41%)
After Hours: 1/3/2023, 8:21:22 PM
Fundamental Rating

1

Taking everything into account, OG scores 1 out of 10 in our fundamental rating. OG was compared to 0 industry peers in the Internet & Direct Marketing Retail industry. OG scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. OG is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

OG had negative earnings in the past year.
OG had a negative operating cash flow in the past year.
OG Yearly Net Income VS EBIT VS OCF VS FCFOG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 0 200M -200M -400M -600M

1.2 Ratios

OG has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OG Yearly ROA, ROE, ROICOG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 0 -100 -200 -300 -400 -500

1.3 Margins

OG does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OG Yearly Profit, Operating, Gross MarginsOG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 0 10 -10 20 -20 -30

4

2. Health

2.1 Basic Checks

OG does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, OG has more shares outstanding
Compared to 1 year ago, OG has a worse debt to assets ratio.
OG Yearly Shares OutstandingOG Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2M 4M 6M 8M 10M
OG Yearly Total Debt VS Total AssetsOG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 500M 1B

2.2 Solvency

OG has an Altman-Z score of 0.92. This is a bad value and indicates that OG is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.92, OG perfoms like the industry average, outperforming 45.68% of the companies in the same industry.
OG has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.00, OG is in the better half of the industry, outperforming 71.60% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.92
ROIC/WACCN/A
WACC5.63%
OG Yearly LT Debt VS Equity VS FCFOG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 0 500M -500M

2.3 Liquidity

A Current Ratio of 2.89 indicates that OG has no problem at all paying its short term obligations.
With an excellent Current ratio value of 2.89, OG belongs to the best of the industry, outperforming 86.42% of the companies in the same industry.
OG has a Quick Ratio of 1.54. This is a normal value and indicates that OG is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of OG (1.54) is better than 65.43% of its industry peers.
Industry RankSector Rank
Current Ratio 2.89
Quick Ratio 1.54
OG Yearly Current Assets VS Current LiabilitesOG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 200M 400M 600M 800M 1B

1

3. Growth

3.1 Past

OG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -261.15%.
OG shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -32.90%.
OG shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.30% yearly.
EPS 1Y (TTM)-261.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-134.04%
Revenue 1Y (TTM)-32.9%
Revenue growth 3Y12.3%
Revenue growth 5YN/A
Sales Q2Q%-46.24%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
OG Yearly Revenue VS EstimatesOG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 1B 2B 3B

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for OG. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OG Price Earnings VS Forward Price EarningsOG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OG Per share dataOG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

OG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ONION GLOBAL LTD

NYSE:OG (1/3/2023, 8:21:22 PM)

After market: 0.1799 -0.06 (-24.41%)

0.238

-0.01 (-4.8%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryInternet & Direct Marketing Retail
Earnings (Last)N/A N/A
Earnings (Next)12-13 2022-12-13/bmo
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.50M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF N/A
P/B 0.02
P/tB 0.02
EV/EBITDA N/A
EPS(TTM)-5.66
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-8.44
FCFYN/A
OCF(TTM)-8.24
OCFYN/A
SpS36.17
BVpS13.9
TBVpS13.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover1.75
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 88.11%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.89
Quick Ratio 1.54
Altman-Z 0.92
F-Score2
WACC5.63%
ROIC/WACCN/A
Cap/Depr(3y)139.19%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-261.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-134.04%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-32.9%
Revenue growth 3Y12.3%
Revenue growth 5YN/A
Sales Q2Q%-46.24%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-247.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1471.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1155.11%
OCF growth 3YN/A
OCF growth 5YN/A